Lifting the veils on transmembrane proteins: Potential anticancer targets

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cancer remains a leading cause of mortality, with poor patient prognosis often due to a lack of specific diagnostic and therapeutic targets.
• Transmembrane proteins (TMEMs) are integral membrane proteins involved in various cellular processes and are implicated in diseases including cancer.
• Aberrant expression of TMEMs in cancer cells can exert pro- or anti-cancer effects and correlate with tumor features and patient outcomes.

Purpose of the Study:

• To review the structures, functions, and roles of transmembrane proteins (TMEMs) in the context of cancer.
• To explore the potential of TMEMs as targets for novel cancer therapies and diagnostic indicators.
• To summarize current scientific perspectives and challenges in preclinical and clinical anticancer research involving TMEMs.

Main Methods:

• Literature review synthesizing existing research on TMEMs in cancer.
• Analysis of the structural and functional characteristics of TMEMs.
• Evaluation of the prognostic and clinicopathological significance of TMEM expression in various tumors.

Main Results:

• TMEMs exhibit altered expression levels in cancer cells, influencing tumor development and progression.
• The expression patterns of TMEMs are associated with prognostic and clinicopathological features across diverse tumor types.
• TMEMs represent promising candidates for targeted cancer therapies and early diagnostic strategies.

Conclusions:

• Transmembrane proteins (TMEMs) play multifaceted roles in cancer, highlighting their importance in tumor biology.
• Targeting TMEMs holds significant potential for developing innovative diagnostic tools and therapeutic interventions for cancer.
• Further preclinical and clinical research is essential to overcome challenges and fully realize the therapeutic promise of TMEMs in oncology.